MedPath

Incidence of Ventilator associated pneumonia in ICU in a cancer centre

Not yet recruiting
Conditions
Malignant neoplasm of upper respiratory tract, part unspecified,
Registration Number
CTRI/2023/10/058331
Lead Sponsor
Malabar cancer centre
Brief Summary

This study is done to know the incidence and risk factors associated with ventilator associated pneumonia in a cancer institute so that we can better manage such patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients who were intubated for more than 48 hours in ICU from 1stJanuary 2020 to 31stDecember 2022.

Exclusion Criteria

Patients who were extubated before 48 hours of ICU admission Patients who already had pneumonia or developed pneumonia within 48 hours of intubation.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To estimate the incidence of VAP in ICU in a tertiary care centre.6 months,1 year,2 year
Secondary Outcome Measures
NameTimeMethod
To predict the risk factors associated with VAP.6 months,1 year,2 year

Trial Locations

Locations (1)

Malabar cancer centre

🇮🇳

Kannur, KERALA, India

Malabar cancer centre
🇮🇳Kannur, KERALA, India
Dr Sonali Opneja
Principal investigator
09765635728
sopneja@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.